Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5491 to 5505 of 7681 results

  1. Which combinations of behaviour change techniques and modes of delivery are effective and cost effective in initiating particular behaviour changes, and in maintaining those changes? How does this vary among people from different socio-demographic groups or with different levels of motivation, access to information or skills? Include research that builds the evidence base on the effectiveness of each behaviour change technique. For example, experimental and meta-analytic work could clarify which behaviour change techniques work when, and for whom.

    Recommendation ID PH49/3 Question Which combinations of behaviour change techniques and modes of delivery are effective and cost effective

    Research recommendation
    Published
    9 June 2015

  2. Hospital escalation policies:- Which components of a hospital escalation policy to deal with surges in demand are the most clinically and cost effective? [See the evidence review on escalation measures.]

    Recommendation ID NG94/17 Question Hospital escalation policies:- Which components of a hospital escalation policy to deal with surges

    Research recommendation
    Published
    15 November 2018

  3. Factors that may influence the use of nicotine replacement therapy and e-cigarettes: Which factors may prevent people who currently smoke tobacco from using other forms of nicotine such as NRT and nicotine-containing e‑cigarettes? Does this vary according to population group, particularly among under-served groups?

    Recommendation ID NG209/10 Question Factors that may influence the use of nicotine replacement therapy and e-cigarettes: Which factors

    Research recommendation
    Published
    17 December 2021

  4. Adjuvant bisphosphonate therapy:- Which groups of people with early and locally advanced breast cancer would benefit from the use of adjuvant bisphosphonates?

    Recommendation ID NG101/2 Question Adjuvant bisphosphonate therapy:- Which groups of people with early and locally advanced breast cancer

    Research recommendation
    Published
    11 December 2018

  5. Which interventions for other communicable diseases could be used to encourage people at increased risk of hepatitis B and C infection to take up the offer of testing and treatment?

    Recommendation ID PH43/8 Question Which interventions for other communicable diseases could be used to encourage people at increased risk

    Research recommendation
    Published
    9 June 2015

  6. Interventions to improve CPAP adherence: Which interventions, including behavioural interventions, are most clinically and cost effective to improve adherence to CPAP in people with OSAHS, obesity hypoventilation syndrome (OHS) and COPD–OSAHS (chronic obstructive pulmonary disease–OSAHS) overlap syndrome who have difficulty using CPAP?

    Recommendation ID NG202/3 Question Interventions to improve CPAP adherence: Which interventions, including behavioural interventions, are

    Research recommendation
    Published
    30 September 2021

  7. Core outcomes for study reporting: Which mental wellbeing and productivity outcomes should be used in a core outcome set for research into workplace mental wellbeing?

    Recommendation ID NG212/05 Question Core outcomes for study reporting: Which mental wellbeing and productivity outcomes should be used

    Research recommendation
    Published
    8 April 2022

  8. What are the benefits, risk and cost effectiveness of enteral nutrition in maintaining remission in the post-surgical period of Crohn's disease?

    Recommendation ID NG129/1 Question What are the benefits, risk and cost effectiveness of enteral nutrition in maintaining remission in

    Research recommendation
    Published
    25 October 2019

  9. 5-aminosalicylate (5-ASA) treatment:- Following successful medical induction of remission of Crohn's disease of the colon, is mesalazine more clinically and cost effective than no treatment?

    Recommendation ID CG152/3 Question 5-aminosalicylate (5-ASA) treatment:- Following successful medical induction of remission of Crohn's

    Research recommendation
    Published
    17 September 2020

  10. Effectiveness and costs of oral health interventions for care home residents:- How effective and cost effective are oral health interventions in care homes including suitableperson-centred outcome measures?

    Recommendation ID NG48/2 Question Effectiveness and costs of oral health interventions for care home residents:- How effective and cost

    Research recommendation
    Published
    24 August 2016

  11. Effectiveness of home visiting following child abuse or neglect:- Are home visiting interventions effective and cost effective in improving parenting and preventingrecurrence of child abuse and neglect in families in which abuse or neglect is occurring or has occurred?

    Recommendation ID NG76/12 Question Effectiveness of home visiting following child abuse or neglect:- Are home visiting interventions effective

    Research recommendation
    Published
    18 October 2018

  12. Effectiveness of 'rescue' cerclage:- What is the clinical effectiveness of 'rescue' cerclage in improving outcomes for women at risk of preterm birth?

    Recommendation ID NG25/3 Question Effectiveness of 'rescue' cerclage:- What is the clinical effectiveness of 'rescue' cerclage in improving

    Research recommendation
    Published
    11 December 2015

  13. Effectiveness of biomarkers for determining level of risk of colorectal cancer:- Which biomarkers, including epigenic and genetic markers, are predictors of colorectal cancer? How should these be used to improve risk stratification?

    Recommendation ID CG118/3 Question Effectiveness of biomarkers for determining level of risk of colorectal cancer:- Which biomarkers, including

    Research recommendation
    Published
    9 June 2015

  14. What is the most clinically and cost-effective tool for diagnosing peripheral arterial disease in people with diabetes?

    Recommendation ID CG147/6 Question What is the most clinically and cost-effective tool for diagnosing peripheral arterial disease in people

    Research recommendation
    Published
    22 January 2021

  15. What is the most clinically and cost-effective tool for establishing the severity of peripheral arterial disease and the impact on mortality, morbidity and limb amputation in people with diabetes?

    Recommendation ID CG147/7 Question What is the most clinically and cost-effective tool for establishing the severity of peripheral arterial

    Research recommendation
    Published
    22 January 2021